S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
NYSEAMERICAN:AMPE

Ampio Pharmaceuticals (AMPE) Stock Forecast, Price & News

$0.29
+0.01 (+3.57%)
(As of 06/2/2023 ET)
Compare
Today's Range
$0.28
$0.31
50-Day Range
$0.20
$0.31
52-Week Range
$0.18
$3.94
Volume
124,885 shs
Average Volume
285,605 shs
Market Capitalization
$4.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Ampio Pharmaceuticals MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
5.38% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Ampio Pharmaceuticals in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$33,298 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.82 out of 5 stars


AMPE stock logo

About Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Stock

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.

Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPE Stock News Headlines

AMPE - Ampio Pharmaceuticals, Inc.
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
See More Headlines

AMPE Price History

AMPE Company Calendar

Last Earnings
5/08/2023
Today
6/03/2023
Next Earnings (Estimated)
8/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NYSEAMERICAN:AMPE
CUSIP
03209T10
Employees
20
Year Founded
N/A

Profitability

Net Income
$-17,080,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.02 per share

Miscellaneous

Free Float
14,960,000
Market Cap
$4.38 million
Optionable
Optionable
Beta
1.48

Key Executives

  • Michael A. Martino
    Chief Executive Officer & Director
  • Daniel G. Stokely
    Chief Financial Officer & Secretary
  • Howard Levy
    Chief Medical Officer
  • Lane Hapke
    Vice President-Manufacturing Operations
  • Laura Goldberg
    Vice President-Quality & Regulatory Operations













AMPE Stock - Frequently Asked Questions

How have AMPE shares performed in 2023?

Ampio Pharmaceuticals' stock was trading at $0.2252 at the beginning of the year. Since then, AMPE stock has increased by 28.8% and is now trading at $0.29.
View the best growth stocks for 2023 here
.

When is Ampio Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 7th 2023.
View our AMPE earnings forecast
.

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE) posted its quarterly earnings results on Monday, May, 8th. The specialty pharmaceutical company reported ($0.26) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Ampio Pharmaceuticals own?
What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "AMPE."

Who are Ampio Pharmaceuticals' major shareholders?

Ampio Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional investors include HRT Financial LP (1.44%). Insiders that own company stock include Dan Stokely, David R Stevens, Holli Cherevka, Michael A Martino and Philip H Coelho.
View institutional ownership trends
.

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $0.29.

How much money does Ampio Pharmaceuticals make?

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) has a market capitalization of $4.38 million. The specialty pharmaceutical company earns $-17,080,000.00 in net income (profit) each year or ($1.8493) on an earnings per share basis.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The official website for the company is ampiopharma.com. The specialty pharmaceutical company can be reached via phone at (720) 437-6500, via email at info@ampiopharma.com, or via fax at 720-437-6501.

This page (NYSEAMERICAN:AMPE) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -